Project CASCADE: Community and Academic Synergy for Cancer Survivorship Care Delivery Enhancement
NCT ID: NCT06883838
Last Updated: 2025-10-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
5584 participants
INTERVENTIONAL
2025-09-01
2029-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Communicating About Sexual Concerns and Dysfunction Effectively (CASCADE) Program
NCT03658161
Supportive Care Service Availability for Cancer Caregivers in Community Oncology Practices
NCT03746314
Improving Survivorship Care Through Enhanced Communication and Coordination: Pilot Study
NCT02111616
Care Coordination for Complex Cancer Survivors in an Integrated Safety Net System
NCT02943265
Prostate Cancer: Family Care for Patients and Spouses
NCT00708968
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Step 1 (2 clinics)-6 months control then 12 months intervention
Survivorship care delivery intervention
Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), the intervention includes three evidence-based components:
1. Training: This will include provider-to-provider tele-mentoring using Enhancing Community Health Outcomes (ECHO).
2. Tracking: This includes systematically assessing cancer history and monitoring survivors' care to plan and organize subsequent care.
3. Coordinating care for cancer survivors. Each clinic leader will designate a staff member (or members) as the care coordinator champion after exploring current clinic staff, skills, and capacity of various staff roles.
Step 2 (2 clinics)-12 months control then 12 months intervention
Survivorship care delivery intervention
Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), the intervention includes three evidence-based components:
1. Training: This will include provider-to-provider tele-mentoring using Enhancing Community Health Outcomes (ECHO).
2. Tracking: This includes systematically assessing cancer history and monitoring survivors' care to plan and organize subsequent care.
3. Coordinating care for cancer survivors. Each clinic leader will designate a staff member (or members) as the care coordinator champion after exploring current clinic staff, skills, and capacity of various staff roles.
Step 3 (2 clinics)-18 months control then 12 months intervention
Survivorship care delivery intervention
Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), the intervention includes three evidence-based components:
1. Training: This will include provider-to-provider tele-mentoring using Enhancing Community Health Outcomes (ECHO).
2. Tracking: This includes systematically assessing cancer history and monitoring survivors' care to plan and organize subsequent care.
3. Coordinating care for cancer survivors. Each clinic leader will designate a staff member (or members) as the care coordinator champion after exploring current clinic staff, skills, and capacity of various staff roles.
Step 4 (2 clinics)- 24 months control then 12 months intervention
Survivorship care delivery intervention
Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), the intervention includes three evidence-based components:
1. Training: This will include provider-to-provider tele-mentoring using Enhancing Community Health Outcomes (ECHO).
2. Tracking: This includes systematically assessing cancer history and monitoring survivors' care to plan and organize subsequent care.
3. Coordinating care for cancer survivors. Each clinic leader will designate a staff member (or members) as the care coordinator champion after exploring current clinic staff, skills, and capacity of various staff roles.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survivorship care delivery intervention
Guided by the Practical, Robust Implementation and Sustainability Model (PRISM), the intervention includes three evidence-based components:
1. Training: This will include provider-to-provider tele-mentoring using Enhancing Community Health Outcomes (ECHO).
2. Tracking: This includes systematically assessing cancer history and monitoring survivors' care to plan and organize subsequent care.
3. Coordinating care for cancer survivors. Each clinic leader will designate a staff member (or members) as the care coordinator champion after exploring current clinic staff, skills, and capacity of various staff roles.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
-employed clinicians (e.g. physicians, nurses, pharmacists, or other allied health professionals) and non-clinician staff of the participating CHC clinics
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Institute (NCI)
NIH
The University of Texas Health Science Center, Houston
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bijal.A.Balasubramanian
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bijal Balasubramanian, MBBS, PhD
Role: PRINCIPAL_INVESTIGATOR
The University of Texas Health Science Center, Houston
Simon Craddock Lee, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Kansas Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The University of Texas Health Science Center, Houston
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HSC-SPH-24-0777
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.